ZymoGenetics is a global biopharmaceutical brand dedicated to discovering, developing, and delivering innovative medicines to patients with serious diseases. With a focus on unmet medical needs, ZymoGenetics is at the forefront of scientific breakthroughs that are revolutionizing disease treatment. They combine the agility of a biotech company with the resources of an established pharmaceutical company, making them a leading biopharma organization powered by talented individuals who drive scientific innovation.

ZymoGenetics takes pride in their advancements in oncology, hematology, immunology, and cardiovascular disease, and their commitment to helping patients prevail over serious illnesses. As global citizens, they conduct their business sustainably and responsibly, striving to create a positive impact in the communities where they operate. ZymoGenetics is dedicated to promoting health equity worldwide and increasing access to life-saving medications for vulnerable populations.

Through their foundation, they support community-based programs that raise cancer awareness and provide care and support to at-risk communities